Clinical Trial Update: Sublingual Cannabidiol for Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sublingual cannabidiol for anxiety has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Staci Gruber, Ph.D. | Conditions: Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2026-03-27